Recent studies have revealed that the sensory nervous system is involved in bone metabolism. However, the mechanism of communication between neurons and osteoblasts is yet to be elucidated. In this study, we investigated the signaling pathways between sensory neurons of the dorsal root ganglion (DRG) and the osteoblast-like MC3T3-E1 cells using an in vitro coculture system. Our findings indicate that signal transduction from DRG-derived neurons to MC3T3-E1 cells is suppressed by antagonists of the AMPA receptor and the NK 1 receptor. Conversely, signal transduction from MC3T3-E1 cells to DRG-derived neurons is suppressed by a P2X 7 receptor antagonist. Our results suggest that these cells communicate with each other by exocytosis of glutamate, substance P in the efferent signal, and ATP in the afferent signal.
Bones are continuously resorbed by osteoclasts and constructed by osteoblasts, the balance of which constantly maintains bone mass. Recent studies have revealed the role of neural systems in the regulation of bone metabolism [1] [2] [3] [4] [5] . Bone tissue is innervated by sympathetic and sensory nerves [6, 7] . Continuous high sympathetic tone induces up-regulation of osteoclastogenesis and osteoclastic activity via b 2 -adrenoceptors in several animal models of osteopenia [8, 9] . Additionally, cell proliferation and differentiation of osteoblasts are stimulated by activation of a 1 -adrenoceptors [10] [11] [12] [13] [14] . These studies have begun to elucidate mechanisms of the sympathetic nervous system and adrenoceptors in the regulation of bone metabolism. However, the role of the sensory nervous system in controlling bone metabolism has been less well studied. Sensory denervation with capsaicin increased bone resorption and decreased bone mineral density [15] . In mice lacking neuron-derived Sema3A, which show a loss of sensory nerve innervation to bone tissue, bone mass and bone formation were decreased [16] . These studies suggest that the sensory nervous system plays an important role in bone homeostasis, but the mechanism is not currently understood.
In general, sensory nerves play important roles in efferent signal transduction, as well as in afferent signal by releasing neurotransmitters from peripheral nerve endings via axon reflexes [17] . Glutamate and neuropeptides, including substance P, calcitonin gene-related peptide (CGRP), neuropeptide Y, and vasoactive intestinal peptide, are known as sensory neurotransmitters. Genetic and pharmacological studies have demonstrated that the receptors of these transmitters are expressed in bone-related cells, including
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osteoblasts and osteoclasts, and are involved in the regulation of bone metabolism [18] [19] [20] [21] . Thus, it is suggested that the sensory nervous system regulates bone mass via both afferent and efferent signal pathways. However, the signal transduction pathway between sensory nerves and bone tissue is still unknown. Previously we have demonstrated direct communication between sympathetic neurons and osteoblastic cells, using an in vitro coculture system and optical measurement of intracellular Ca 2+ [22] . In the present study, we investigated the mechanisms of cell communication between mouse dorsal root ganglion (DRG)-derived sensory neurons and mouse osteoblast-like cells, MC3T3-E1 cells. Pharmacological analysis revealed that signal transduction from DRG-derived neurons to MC3T3-E1 cells was mediated by glutamate and substance P receptors. On the other hand, the signal transduction from MC3T3-E1 cells to DRG-derived neurons was mediated by P2X purinergic receptors. These observations suggest that sensory neurons and osteoblasts communicate directly and bidirectionally via glutamate, substance P, and ATP.
Materials and methods

Cell culture
All of the animal experimental protocols used in the present study were approved by the Aichi-Gakuin University Animal Research Committee, and performed in accordance with the guidelines of the National Institutes of Health and the Japanese Pharmacological Society. Primary cultures of DRGderived neurons were performed using the following methods: DRG tissue was dissected from BALB/c mice within 2-7 days of birth (Japan SLC, Shizuoka, Japan), and washed in Hank's balanced salt solution (HBSS) containing 10 mM HEPES (pH adjusted to 7.4). Each ganglion was incubated for 1 h at 37°C in HBSS buffer (2 mL) containing 0.125% trypsin (Sigma-Aldrich, St. Louis, MO, USA). The resulting cell suspension was plated at a density of 0. Cells of the mouse osteoblastic cell line, MC3T3-E1, were purchased from the Riken Cell Bank (Ibaraki, Japan). Cells were cultured in alpha-modified minimum essential medium (aMEM, Invitrogen), containing 10% FBS, penicillin (100 IUÁmL À1 ), and streptomycin (100 lgÁmL À1 ).
The human osteoblasts, SaM-1 cells, were provided by Dr. Koshihara, who prepared them with informed consent from an explant of ulnar periosteum tissue from a 20-yearold male patient who underwent curative surgery [23] . These cells have a mitotic lifespan of 34 population doubling levels (PDLs), and we used them at PDL of 22-24 for our experiments. We have previously confirmed that the cells are capable of calcifying at this level [24] . Cells were cultured in aMEM, containing 10% FBS and kanamycin (60 lgÁmL
À1
).
For coculture experiments, MC3T3-E1 cells (1 9 10 4 cells per dish) were added to 48-h-old cultures of DRGderived neurons, and the cocultures were then incubated for 48 h. All cultures were maintained at 37°C in 95% humidified air containing 5% CO 2 .
Optical measurements of [Ca
2+ ] i
Cells were loaded with Cal-520 (2.5 lM) (AAT Bioquest, Sunnyvale, CA, USA) for 30 min and washed three times with extracellular solution, which contained 124 mM NaCl, 3 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 14 mM D-glucose, and 10 mM HEPES (pH adjusted to 7.4 with NaOH), immediately prior to use. Subsequently, the dish was transferred to a superfusion chamber on the stage of a confocal laser scanning microscope (LSM710, Carl Zeiss, Hallbergmoos, Germany). Cells were superfused with extracellular solution at a rate of 1.5 mLÁmin
À1
. The fluorescence was recorded every 1 s at room temperature at an excitation wavelength of 488 nm, and the data were analyzed using ZEN 2009 software (Carl Zeiss). Stock solutions of drugs were prepared and diluted 1000-fold into extracellular solution immediately prior to use, and they were applied by bath perfusion. ] i elevation after treatment with brefeldin A to that in control. Data represent the mean value AESEM of three independent experiments. *P < 0.05 compared with DRG.
Electrical stimulation
Cells were superfused with extracellular solution, which contained 124 mM NaCl, 3 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 14 mM D-glucose, and 10 mM HEPES (pH adjusted to 7.4 with NaOH), at a rate of 1.5 mLÁmin Stim.
borosilicate glass capillaries (1.5 mm outer diameter and 1.17 mm inner diameter) (Harvard Apparatus, Edenbridge, UK), using a micropipette puller (PC-10, Narishige, Tokyo, Japan). A glass microelectrode filled with the extracellular solution (1-2MΩ) was attached to the three-axis micromanipulator, and its tip was moved to approximately 50 lm from the target nerve fiber (Fig. 1A) . A voltage pulse (0.5 s in duration) was applied at a stimulus intensity adjusted to 1.1 times the threshold voltage.
Chemicals
A438079, AF353, DL-2-amino-5-phosphopentanoic acid (APV), brefeldin A, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), FK888, HOE140, mefloquine, monensin, prazosin, and suramin were purchased from Sigma Aldrich. LY341495 was purchased from Tocris Bioscience (Bristol, UK). Bradykinin was purchased from Peptide Institute (Osaka, Japan). All other chemicals used were of reagent grade.
Statistical analysis
All data are expressed as mean AE SEM. ] i elevation was not seen in the surrounding cells having no contact with the nerve fiber (Fig. 1B) . Ca 2+ responses in these cells were reproducible by repeated stimulation. The lag-time from nerve fiber to MC3T3-E1 cell varied from several to several tens of seconds, depending on the pair of cells. Previous studies have demonstrated that cell adhesion molecules regulate adhesive strength between neuron and other cells, and they also contribute shortening lag-time for activating target cells after nerve stimulation in the coculture system [25, 26] . Therefore, the differences in lag-time may be due to variation in adhesive strength between nerve fiber and MC3T3-E1 cells. Subsequently, we examined whether vesicular exocytosis from DRG-derived neurons is implicated in Ca 2+ response in MC3T3-E1 cells, using exocytosis inhibitors, monensin, which prevents vesicle formation from the Golgi apparatus, and brefeldin A, which causes disruption of the Golgi apparatus. Treatment with monensin at 10 lM for 60 min suppressed Ca 2+ elevation in MC3T3-E1 cells, not in nerve fibers (Fig. 1C) . Similar results were observed following treatment with brefeldin A at 10 lM for 30 min (Fig. 1D) . These results indicate that direct signal transduction pathways from neurons to osteoblasts are formed via exocytosis of specific neurotransmitters.
Identification of neurotransmitters involved in efferent signal transduction between sensory neurons and osteoblastic cells
Sensory neurons can be subdivided into nonpeptidergic and peptidergic neurons. Previous studies have demonstrated that glutamate and neuropeptides, including CGRP and SP, are independently released from nonpeptidergic and peptidergic peripheral nerve terminals, respectively [27, 28] ] i elevation in MC3T3-E1 cells was suppressed by CNQX in 8 of 14 cells tested, and by FK888 in 6 of 14 cells, and the two populations revealed to be mutually exclusive ( Fig. 2A,B) . In our previous study, signal transduction from superior cervical ganglion (SCG)-derived sympathetic neurons to MC3T3-E1 cells in a coculture system was suppressed by prazosin, an a 1 -adrenoceptor antagonist [22] . However, in the present study, signal transduction from DRGderived neurons to MC3T3-E1 cells was not affected ] i elevation in the presence of prazosin to that in control (n = 5). Data represent the mean value AE SEM. **P < 0.05 compared with DRG. by prazosin (10 lM) (n = 5, Fig. 2C ). It is consistent with the studies which revealed that dopamine b-hydroxylase, the enzyme responsible for synthesizing noradrenaline, is absent in DRG neurons [29, 30] . These results suggest that glutamatergic and peptidergic neurons, but not adrenergic neurons, were included in the DRG-derived neurons used in this study.
Afferent signal transduction between sensory neurons and osteoblastic cells
To examine direct signal transduction from MC3T3-E1 cells to DRG-derived neurons, we required a stimulation method that would allow direct and selective activation of MC3T3-E1 cells. Previous studies have mechanical stimulation by contact with glass micropipette as a selective cell stimulation method [31, 32] . However, mechanical stimulation by glass micropipettes haa the potential to damage cells, which can induce leakage of ATP [33] . Thus (Fig. 3A) . To confirm whether high reactivity to bradykinin is the common characteristic of osteoblasts, we also evaluated the concentration-response relationships of bradykinin in SaM-1 cells, nonimmortalized human periosteum-derived osteoblasts. Previous studies have demonstrated that these cells retain the characteristics of normal osteoblasts [23, 24] . Similar to the results in MC3T3-E1 cells, bath application of bradykinin also induced [Ca 2+ ] i elevation at picomolar levels in SaM-1 cells. The EC 50 value was 3.3 AE 0.2 9 10 À12 M (Fig. 3A) . Bradykinin-
] i elevation was suppressed by 100 nM of HOE140, a B 2 bradykinin receptor antagonist, in all of these cell types (Fig. 3B) . The difference in reactivity to bradykinin between MC3T3-E1 cells and DRGderived neurons was greatest at 1 nM (1 9 10 À9 M).
Thus, we used bath application of 1 nM of bradykinin to selectively stimulate MC3T3-E1 cells in the following experiments.
In a coculture system, bath application of bradykinin at 1 nM induced [Ca 2+ ] i elevation in both MC3T3-E1 cells and DRG-derived neurons connected to MC3T3-E1 cells (Fig. 4A-C ] i elevation in DRG-derived neurons, but had no effect in MC3T3-E1 cells, as indicated by response rates of 4.4 AE 2.5% and 87.5 AE 12.5%, respectively (Fig. 4D) ] i elevation in DRG-derived neurons is thought to be induced by signal transduction from MC3T3-E1 cells.
Next, we examined the signal transduction pathway from MC3T3-E1 cells to DRG-derived neurons. It has been reported that vesicular exocytosis, gap junction, and transmitter release via hemichannels, such as pannexin-1, play important roles in intercellular signal transduction in several tissues [31, 36, 37] . Thus, we examined the effects of monensin, brefeldin A, exocytosis inhibitors (see above for more detailed information), and mefloquine, an inhibitor of gap junction channel and pannexin-1, on the signal transduction from MC3T3-E1 cells to DRG-derived neurons. In the presence of mefloquine (3 lM), [Ca 2+ ] i elevation was unaffected in both MC3T3-E1 cells and DRG-derived neurons (Fig. 5A) . Similarly, pretreatment with monensin or brefeldin A, did not alter [Ca 2+ ] i elevation in MC3T3-E1 cells, whereas [Ca 2+ ] i elevation in DRGderived neurons was significantly suppressed (Fig. 5B,  C) . These results indicate that direct signal transduction pathway from osteoblasts to sensory neurons can be formed via exocytosis of specific neurotransmitters.
Identification of neurotransmitters involved in the afferent signal transduction between sensory neurons and osteoblastic cells
Preceding studies have demonstrated that some neurotransmitters, including ATP and glutamate, are released from osteoblasts upon exposure to various stimulations [36, 38, 39] . To identify the neurotransmitters involved in signal transduction from MC3T3-E1 cells to DRG-derived neurons, we examined the effects of suramin, a P2X purinergic receptor antagonist, AF353, a P2X 2/3 receptor selective antagonist, A438079, a P2X 7 receptor selective antagonist, CNQX, APV, an NMDA glutamate receptor antagonist, and LY341495, a metabotropic glutamate receptor antagonist, on the Ca 2+ response induced by bath application of bradykinin in a coculture system. In the presence of suramin (10 lM), the [Ca 2+ ] i elevation induced by bath-applied bradykinin was suppressed in DRG-derived neurons, but not in MC3T3-E1 cells (Fig. 6A) . Similarly, [Ca 2+ ] i elevation in DRG-derived neurons was suppressed by A438079 (Fig. 6B ). In contrast, AF353, and a mixture of CNQX, APV, and LY341495, did not suppress [Ca 2+ ] i elevation in both MC3T3-E1 cells and DRG-derived neurons (Fig. 6C,  D) . These results suggest that vesicular exocytosis of ATP from MC3T3-E1 cells induces [Ca 2+ ] i elevation in DRG-derived neurons via P2X 7 receptors.
Discussion
Recent studies have demonstrated that the sensory nervous system plays an important role in bone metabolism [15, 16] . Although it remains unclear how sensory nerves and bone-related cells communicate. In bone tissue, it is difficult to observe cell communication directly using in vivo or in situ methods, due to its hardness and opacity. To investigate cell communication between sensory nerves and osteoblasts, we used a coculture system comprising DRG-derived neurons and MC3T3-E1 cells.
In a coculture system, electrical stimulation of DRG-derived neuron-induced [Ca 2+ ] i elevation not only in the stimulated neuron but also in MC3T3-E1 cells attached to the stimulated cell. The Ca 2+ response in MC3T3-E1 cells was suppressed by treatment with exocytosis inhibitors, monensin, and brefeldin A (Fig. 1) . Additionally, both glutamate-mediated and substance P-mediated Ca 2+ responses were independently revealed ( Fig. 2A,B) . Preceding studies have demonstrated close membrane contact and synaptic structure in cocultures comprising DRG-derived sensory neurons and osteoblasts, by electron microscopy analysis [32, 40] . Immunoreactivity to synapsin, a synaptic-related protein, has also been observed in nerve fibers attached to osteoblasts [40] . These results suggest that direct signal transduction from sensory neurons to osteoblasts occurs via exocytosis of glutamate or substance P. In most peptidergic sensory neurons, substance P is coexpressed with CGRP [28, 41] . However, because CGRP receptors are usually coupled with Gs protein, it is difficult to detect its activation using Ca 2+ -imaging methods. Thus, we cannot rule out the involvement of CGRP or other neuropeptides in efferent signal transduction between sensory neurons and osteoblasts. Our results suggest that both nonpeptidergic and peptidergic sensory neurons are capable of establishing synaptic contact with osteoblasts. Immunohistochemical analysis has revealed that a marker of A-fiber sensory neurons, neurofilament 200, and markers of peptidergic C-fiber sensory neurons, CGRP and substance P, but not a marker of nonpeptidergic C-fiber sensory neurons, Mas-related G protein-coupled receptor member d, are expressed in nerve fibers innervating bone tissue [7] . Innervation of glutamate-containing nerve fibers in bone tissue has also been reported [42] . Additionally, vesicular glutamate transporter, which is responsible for filling synaptic vesicles with glutamate, was not expressed in the peripheral ending of peptidergic neurons [28] . According to these studies, it is likely that glutamate in A-fibers, and neuropeptides in C-fibers, are involved in direct synaptic transmission with osteoblasts.
The primary function of the sensory nervous system is thought to be afferent signal transduction to the central nervous system. The bone tissue is regularly exposed to various stimuli, including mechanical, acidic and inflammatory stimulation. Although the periosteum is richly innervated by sensory neurons, the number of neurons in mineralized bone and bone marrow is limited [6, 7] . It seems to be difficult for the sensory nerve to receive information from the deep portion of bones directly. Therefore, we suggest that bone surface cells, including osteoblasts and osteoclasts, have a role as the primary sensor of various stimuli, and transfer information to sensory nerves. In the present study, both mouse and human osteoblasts had higher reactivity to bradykinin than that in DRGderived neurons (Fig. 3A) . Additionally, signal transduction via exocytosis from MC3T3-E1 cells to DRGderived neurons was induced by application of bradykinin at a concentration below threshold in DRG-derived neurons (Figs 4,5) . Furthermore, we suggest that ATP and its receptor P2X 7 are involved in afferent signal transduction from MC3T3-E1 cells (Fig. 6 ). Bradykinin is known as an inflammatory mediator and is also involved in bone metabolism [43, 44] . Thus, our results suggest that inflammatory signals in bone tissue are first received by osteoblasts, and are then transferred to sensory nerves. Several pathways have been reported for releasing ATP from osteoblasts, including hemichannels, P2X 7 receptors, and vesicular exocytosis [31, 36, 45] . In the present study, exocytosis inhibitors strongly suppressed signal transduction from MC3T3-E1 cells to DRG-derived neurons (Fig. 5) . These results indicate that bradykinin-induced ATP release from osteoblasts is mainly via exocytosis. Many studies have demonstrated that P2X 2/3 receptors play an important role in ATPmediated response in DRG neurons [46, 47] . However, in the present study, AF353, a P2X 2/3 receptor antagonist, did not affect Ca 2+ response in DRG-derived neurons (Fig. 6) . It has been also reported that P2X 7 in peripheral nerve endings is involved in the nociception of inflammatory pain [48] . These results imply that peripheral endings of sensory nerves receive ATP signals from osteoblasts via the P2X 7 receptor.
In conclusion, the results of this study suggest that sensory nerves and osteoblasts are capable of forming direct signal transduction pathways, and communicating bidirectionally. Furthermore, we suggest that glutamate and neuropeptides are involved in the efferent signal, and that ATP is involved in the afferent signal. Preceding studies have suggested that the sensory nervous system positively regulates bone mass [15, 16] . Further in vivo study is needed to reveal the function of these neurotransmitters in sensory nerve-mediated regulation of bone metabolism. The results presented in this study will further our understanding of the mechanisms regulating bone metabolism by the sensory nervous system, and aid in the development of new therapeutic strategies for osteoporosis.
